Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HSIC
Strong BuyFLAGHenry Schein, Inc. · Healthcare · United States · $10.0B · Avg Vol: $109M/d
Henry Schein has strong momentum M71 and quality Q55 with a buyback and a nominal insider buy, but value at V48 is below the calibrated floor, so stage one fails.
COMPANY DESCRIPTION
Henry Schein, Inc. is the world's largest provider of healthcare products and services to office-based dental and medical practitioners, distributing a comprehensive array of medical, dental, and animal health supplies, equipment, and technology solutions. Henry Schein benefits from its extensive global distribution network, strong relationships with healthcare professionals, and vast product catalog. Its value proposition lies in efficient supply chain management and integrated technology solutions for practitioners.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 12.6B | 12.3B | 12.7B | 13.2B | 1.4% | 13.6B | 13.9B | 14.4B | 4.6% |
| EPS | 4.51 | 3.95 | 3.18 | 3.07 | 3.29 | -7.6% | 3.43 | 3.56 | 3.97 | 9.9% |
| Shares | — | 131.8M | 129.2M | 124.2M | 115.8M | -12.2% | 111.4M | — | — | — |
| Debt | — | 1.5B | 2.7B | 2.9B | 3.4B | 31.9% | 3.8B | — | — | — |
| Equity | — | 3.4B | 3.7B | 3.4B | 3.2B | -2.0% | — | — | — | — |
| Op CF | — | 602.0M | 500.0M | 848.0M | 712.0M | 5.8% | 700.0M | — | — | — |
| Inv CF | — | -276.0M | -1.1B | -430.0M | -400.0M | — | — | — | — | — |
| Fin CF | — | -315.0M | 701.0M | -510.0M | -188.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HSIC are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HSIC | Henry Schein, Inc.(you) | $10.0B | 84 | Strong Buy |
| CAH | Cardinal Health, Inc. | $54.6B | 91 | Strong Buy |
| COR | Cencora, Inc. | $61.5B | 65 | Hold |
| MCK | McKesson Corporation | $104.2B | 75 | Buy |
| UHS | Universal Health Services, Inc. | $10.1B | 83 | Strong Buy |
| ALGN | Align Technology, Inc. | $11.2B | 86 | Strong Buy |
| BTSG | BrightSpring Health Services, Inc. | $11.7B | 87 | Strong Buy |
| HQY | HealthEquity, Inc. | $8.0B | 82 | Strong Buy |
| HNGE | Hinge Health, Inc. | $7.0B | 83 | Strong Buy |
| DVA | DaVita Inc. | $11.5B | 89 | Strong Buy |
Peer medians: ROE -25.9% · P/E 29.6x · Gross margin 58.8%